Skip to Main Content
Wexler Boley & Elgersma LLP
  • Our Firm
    • Who We Serve
      • Shareholders
      • Whistleblowers
      • Consumers
      • Businesses
      • Government Entities
    • Our Professionals
    • Working with Wexler Boley & Elgersma LLP
    • Locations
    • News
    • Careers
    • Report Your Concern
    • Testimonials
  • Practice Areas
    • Antitrust Litigation
    • Business & Commercial Litigation
    • Securities & Corporate Governance
    • Healthcare Litigation
    • Consumer Protection
    • Whistle Blower False Claims Litigation
    • Government Representation
    • Employment Litigation
  • Cases
    • Antitrust Litigation Cases
    • Business & Commercial Litigation Cases
    • Consumer Protection Cases
    • Employment Litigation Cases
    • Government Representation Cases
    • Healthcare Litigation Cases
    • Mass Tort Litigation Cases
    • Securities & Corporate Governance Cases
    • Whistle Blower False Claims Cases
  • Investigations
    • Similac Toxic Infant Formula Lawsuit
    • Kid’s Castle Biometric Privacy Lawsuit
    • Contaminated Baby Food Lawsuit
    • Fatal Sportmix Pet Food Recall Class Action Lawsuit
    • Claire’s Data Breach Lawsuit
    • Insurance Denial for Mental Health and Substance Abuse Treatment
    • Perpetual Sales Litigation
    • Railroad Price-Fixing Lawsuit
    • Medicare Advantage Fraud Litigation
    • Biometric Fingerprinting Litigation
  • Blog
  • Contact Us
See all blog posts
4.2.2018

Starbucks Ordered to Add Cancer Warnings on Coffee in California

By Brian Lynch
In The News, You Should Know, For Consumers

Starbucks ordered to add cancer warnings on coffee in California

California is often seen as a laid back, easygoing state, but they are extremely serious when it comes to informing citizens about potentially cancer-causing products. We’ve previously written about California’s Safe Drinking Water and Toxic Enforcement Act, and how it requires businesses and corporations like Monsanto to include clear warnings about possible carcinogens contained in their products. West coast coffee lovers may soon become more familiar with this law, as a Los Angeles judge has ruled that Starbucks and other coffee retailers must display cancer warnings on coffee sold in California.

The decision was reached following a lawsuit filed in 2010 by the Council for Education and Research on Toxics. The group alleges that Starbucks and similar ready-to-drink coffee companies should be required to reduce levels of acrylamide (a known carcinogenic chemical produced in high levels during the bean roasting process) or warn consumers of the potential risk by putting cancer warnings on coffee sold in the state.

Despite claims by the coffee manufacturers that removing acrylamide from their products isn’t feasible without sacrificing flavor, as well as citing existing U.S. dietary guidelines stating that coffee can be part of a healthy lifestyle, the court sided with the plaintiffs. In a proposed ruling on Wednesday, March 28, 2018, Los Angeles Superior Court Judge Elihu Berle stated that coffee makers failed to show there was no significant risk from acrylamide in roasted coffee beans.

“While plaintiff offered evidence that consumption of coffee increases the risk of harm to the fetus, to infants, to children and to adults, defendants’ medical and epidemiology experts testified that they had no opinion on causation,” Judge Berle wrote in his proposed ruling. “Defendants failed to satisfy their burden of proving … that consumption of coffee confers a benefit to human health.”

The lawsuit calls for fines up to $2,500 per person for each exposure to acrylamide since 2002. Considering California’s population is nearly 40 million, this could be a massive wakeup call to companies who fail to disclose potential cancer risks associated with their products.

Starbucks and other defendants have until April 10, 2018 to file objections to the decision.

Share

No Comments

Leave a Reply Cancel reply

Receive News Updates

Get the latest from Wexler Wallace LLP & stay informed.

Categories

  • Media Appearances
  • Uncategorized
  • Columns
    • Guest Post
    • Ken Wexler
    • Ed Wallace
  • Practice Areas
    • Consumer Protection
    • Mass Tort Litigation
    • Business & Commercial Litigation
    • Healthcare Litigation
    • Employment Litigation
  • Cases
  • Hall Of Shame
    • Villain Of The Week
  • In The News
    • Public Victories
  • Featured Investigations
  • The Firm
    • News releases
    • Around The World
    • Our Professionals
    • Chicago
  • You Should Know
    • For Investors
    • For Businesses
    • For Consumers
  • Featured Cases
  • awards
  • Facebook
  • Twitter
  • LinkedIn
Image

311 S. Wacker Drive,
Suite 5450
Chicago, IL 60606
P_312.346.2222
F_312.346.0022

  • Our Firm
  • Practice Areas
  • Cases
  • Investigations
  • Newsroom
  • Blog
  • Contact Us
  • Sitemap
  • Privacy Statement
  • Legal Disclaimer

2022 © Wexler Boley & Elgersma LLP